VERA insider trading
HealthcareVera Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About Vera Therapeutics, Inc.
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with serious immunological diseases. The company's lead product candidate consists of atacicept, a fully humanized TACI-Fc fusion protein that binds B-cell activating factor (BAFF) and A proliferation-inducing ligand (APRIL), which is self-administered at home as a subcutaneous injection being evaluated for the treatment of immunoglobulin A nephropathy (IgAN). It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections that has completed phase 2 clinical trial; and VT-109, a novel BAFF/APRIL dual-inhibitor B cell maturation antigen (BCMA) molecule to treat B cell mediated autoimmune diseases. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.
Company website: veratx.com
VERA insider activity at a glance
FilingIQ has scored 395 insider transactions for VERA since May 17, 2021. The most recent filing in our index is dated May 12, 2026.
Across the full history, 48 open-market purchases
and 176 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on VERA insider trades is 60.4/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest VERA Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading VERA
13F funds holding VERA
Frequently asked
- How many insider trades does FilingIQ track for VERA?
- FilingIQ tracks 395 Form 4 insider transactions for VERA (Vera Therapeutics, Inc.), covering filings from May 17, 2021 onwards. 17 of those were filed in the last 90 days.
- Are VERA insiders net buyers or net sellers?
- Across the full Form 4 history for VERA, 48 transactions (12%) were open-market purchases and 176 (45%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does VERA insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is VERA in?
- Vera Therapeutics, Inc. (VERA) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $3.01B.
Methodology & sources
Every VERA insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.